Talk:Estradiol (medication)

Move discussion in progress
There is a move discussion in progress on Talk:Lithium (medication) which affects this page. Please participate on that page and not in this talk page section. Thank you. —RMCD bot 23:15, 28 January 2019 (UTC)

Foundations 2 2019, Group 2a goals
- Add usages, especially in IVF - Expand on side effects and overdose. Include unopposed estradiol therapy Laurafansun (talk) 22:16, 29 July 2019 (UTC)

Group 2C edits for group 2a

1. The group’s edit have improved the knowledge base for estradiol medication. In terms of Menopause, the editor clarified that using estrogen alone would increase risk of endometrial cancer. As well as emphasizing that menopausal hormone therapy may not be for suitable for everyone especially based on certain health comorbidities. However it would be best to include an additional source to support this statement.

2. Yes, the group has achieved their goals of expanding information about estradiol therapy for menopausal therapy.

Q1: The draft reflects a neutral point of view due to encouraging patients to seek medical care prior to initiating estradiol therapy. Blu65 (talk) 21:54, 5 August 2019 (UTC) Q2: Yes, editor provides verifiable source for edits. For statement including that estradiol may not be suitable for all patients however it would be best to include an additional citation. Crystalnguyentan (talk) 21:51, 5 August 2019 (UTC) Q3: Edits formatted are consistent with Wikipedia’s manual. Rgonzalezrios (talk) 01:22, 6 August 2019 (UTC) Q4: There is no evidence of plagiarism or copyright violation. Yalda22 (talk) 21:46, 5 August 2019 (UTC)Yalda22

Eek! Found a predatory journal in the reflist
According to the Beall's list, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS) is a predatory journal. Predatory Journals take advantage of authors by asking them to publish for a fee without providing peer-review or editing services.

(In reference to the following source appearing in this article): 

Bagade O, Pawar V, Patel R, Patel B, Awasarkar V, Diwate S (2014). "Increasing use of long-acting reversible contraception: safe, reliable, and cost-effective birth control" (PDF). World J Pharm Pharm Sci. 3 (10): 364–392. ISSN 2278-4357. Archived from the original (PDF) on 10 August 2017. Retrieved 27 November 2016.

Atomic putty? Rien! 15:08, 24 May 2023 (UTC)


 * (I'm removing the offending reference per WP:MEDRS)   Atomic putty? Rien!  15:23, 24 May 2023 (UTC)